📝 Aster DM Quality Care Limited — results explained
Quarter ended June 2026 (Q1 FY27)
Aster DM Quality Care Limited reported revenue of ₹726 crore for the quarter ended June 2026 (Q1 FY27), up 18.4% from ₹613 crore in the same quarter last year, and up 10.8% sequentially over the March 2026 quarter.
The company reported a net loss of ₹14 crore, against a net profit of ₹81 crore in the same quarter last year. Earnings per share (EPS) came in at ₹-0.28.
Operating profit stood at ₹147 crore — an operating margin (OPM) of 20.3%, compared with 21.9% in the year-ago quarter.
Full year and trailing twelve months
For the full year FY26, Aster DM Quality Care Limited posted revenue of ₹2,616 crore, a growth of 42.3% over FY25, with a net profit of ₹268 crore (up 116.5% year-on-year).
On a trailing-twelve-month (TTM) basis, revenue stands at ₹2,729 crore with a net profit of ₹173 crore.
Valuation snapshot
At the current price of ₹674.35, ASTERDM has a market capitalisation of ₹58,781 crore and a trailing P/E of about 340.4.
Within the Medical Care Facilities industry, it is the 5th-largest of the 11 companies we track by market value.
Shareholding pattern
As of Jul 2026, promoters held 53.72%, foreign institutional investors (FIIs) 10.31%, domestic institutional investors (DIIs) 16.48%, public shareholders 19.49% of Aster DM Quality Care Limited.
Promoter holding rose from 40.39% to 53.72% over the latest period.